The binding of OTULIN restrains LUBAC activity to prevent TNF-driven immunopathology
Molecular Cell · 2026-11 · 86 (21) · 4513-4529.e13
DOI: 10.1016/j.molcel.2026.09.039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-11. Verfasst von Wenxin Lyu und 11 weiteren Autor:innen. Beteiligte Einrichtung: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Endopeptidases, Ubiquitin. Die Arbeit nennt 73 Literaturangaben. Gefördert von: Novo Nordisk Foundation, Lundbeck Foundation, Wellcome Trust.
Abstract (Originalsprache)
Met1-linked ubiquitin chains (Met1-Ub), synthesized by the linear ubiquitin chain assembly complex (LUBAC) and disassembled by the deubiquitinase OTULIN, regulate inflammatory signaling and cell death. OTULIN activity prevents tumor necrosis factor (TNF)-driven autoinflammatory pathology and embryonic lethality, but the role of the direct OTULIN-LUBAC interaction remains unclear. Here, we show that mice harboring a point mutation in the OTULIN peptide:N-glycanase/UBA- or UBX-containing proteins (PUB)-interacting motif (OTULINY56A), which disrupts LUBAC binding, are viable without spontaneous pathology but are highly sensitive to TNF-induced toxicity and TNF-mediated immunopathology during Listeria monocytogenes infection. Mechanistically, the OTULIN-LUBAC interaction prevents Met1-linked autoubiquitination, thereby limiting LUBAC activity and Met1-Ub conjugation on non-LUBAC substrates. Disrupting the OTULIN-LUBAC interaction increased Met1-Ub accumulation at the TNF receptor signaling complex, which stabilized the signaling complex, increased nuclear factor-kappa B (NF-κB) signaling, and, unlike loss of OTULIN or its activity, protected from TNF-induced apoptosis. Collectively, we identify the OTULIN-LUBAC interaction as a critical brake restricting LUBAC function and Met1-Ub-dependent signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
- Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
- Department of Biotechnology and Biomedicine, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.
- LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, Unive…
Förderung
- Novo Nordisk Foundation
- Lundbeck Foundation
- Wellcome Trust
- UK Research and Innovation Medical Research Council
- Københavns Universitet
- Ludwig Institute for Cancer Research
- LEO Foundation
- University of Oxford
Zitieren
APA
Lyu, W., Fiil, B. K., Rizk, J., Kjær, M., Sauerland, M. B., Špokaitė, S., Ma, B., Jessen, M., Kulvicki, H., Damgaard, R. B., Elliott, P. R., & Gyrd-Hansen, M. (2026). The binding of OTULIN restrains LUBAC activity to prevent TNF-driven immunopathology. Molecular Cell, 86(21), 4513-4529.e13. https://doi.org/10.1016/j.molcel.2026.09.039
Vancouver
Lyu W, Fiil BK, Rizk J, Kjær M, Sauerland MB, Špokaitė S, et al. The binding of OTULIN restrains LUBAC activity to prevent TNF-driven immunopathology. Molecular Cell. 2026;86(21):4513-4529.e13. doi:10.1016/j.molcel.2026.09.039
BibTeX
@article{Lyu2026,
author = {Lyu, Wenxin and Fiil, Berthe Katrine and Rizk, John and Kjær, Majken and Sauerland, Max Benjamin and Špokaitė, Saulė and Ma, Biao and Jessen, Malin and Kulvicki, Hanna and Damgaard, Rune Busk and Elliott, Paul R and Gyrd-Hansen, Mads},
title = {The binding of OTULIN restrains LUBAC activity to prevent TNF-driven immunopathology},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {21},
pages = {4513--4529.e13},
doi = {10.1016/j.molcel.2026.09.039}
}
EUVIMED